Elevated Serotonin 1A Binding in Remitted Major Depressive Disorder: Evidence for a Trait Biological Abnormality
暂无分享,去创建一个
Ramin V. Parsey | Maria A. Oquendo | Gregory M. Sullivan | R. Parsey | M. Oquendo | J. Mann | Jeffrey M. Miller | G. Sullivan | R. Todd Ogden | Kathleen G. Brennan | J. John Mann | R. Todd Ogden | J. John Mann | M. Oquendo | Todd Ogden
[1] S Kasper,et al. Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders , 2009, Molecular Psychiatry.
[2] P. Albert,et al. Transcriptional regulation at a HTR1A polymorphism associated with mental illness , 2008, Neuropharmacology.
[3] R Todd Ogden,et al. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. , 2008, Journal of psychiatric research.
[4] J. Oehler,et al. Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice. , 2008, European journal of pharmacology.
[5] D. Nutt,et al. Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. , 2008, The British journal of psychiatry : the journal of mental science.
[6] Juha Markkula,et al. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. , 2008, The international journal of neuropsychopharmacology.
[7] M. Boldrini,et al. Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. , 2008, Journal of psychiatric research.
[8] B. Hanusa,et al. Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. , 2008, Fertility and sterility.
[9] D. Kupfer,et al. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. , 2007, Nuclear medicine and biology.
[10] P. Cowen,et al. ‘It's not over when it's over’: persistent neurobiological abnormalities in recovered depressed patients , 2007, Psychological Medicine.
[11] G. Escolar,et al. Hormonal response to buspirone is not impaired in major depression , 2007, Human psychopharmacology.
[12] D. Kupfer,et al. Measurement of 5‐HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY‐100635 , 2007, Synapse.
[13] Wolfgang Wadsak,et al. Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder , 2007, Biological Psychiatry.
[14] David Goldman,et al. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. , 2007, Archives of general psychiatry.
[15] Gavin P. Reynolds,et al. Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT2A receptor binding in the rat , 2007, Psychopharmacology.
[16] A. Gjedde,et al. Parametric and Regional Maps of Free Serotonin 5HT1A Receptor Sites in Human Brain as Function of Age in Healthy Humans , 2007, Neuropsychopharmacology.
[17] A. Schene,et al. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies , 2007, Molecular Psychiatry.
[18] David P. Friedman,et al. Behavioral depression and positron emission tomography-determined serotonin 1A receptor binding potential in cynomolgus monkeys. , 2006, Archives of general psychiatry.
[19] Ramin V. Parsey,et al. Altered Serotonin 1A Binding in Major Depression: A [carbonyl-C-11]WAY100635 Positron Emission Tomography Study , 2006, Biological Psychiatry.
[20] R Todd Ogden,et al. Higher 5-HT1A Receptor Binding Potential During a Major Depressive Episode Predicts Poor Treatment Response: Preliminary Data from a Naturalistic Study , 2006, Neuropsychopharmacology.
[21] J. Mann,et al. Brain Serotonin1A Receptor Binding in Major Depression Is Related to Psychic and Somatic Anxiety , 2005, Biological Psychiatry.
[22] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[23] Victoria Arango,et al. Regional Heterogeneity of 5-HT1A Receptors in Human Cerebellum as Assessed by Positron Emission Tomography , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] R Todd Ogden,et al. Estimation in regression models with externally estimated parameters. , 2005, Biostatistics.
[25] Michael G Stabin,et al. Biodistribution and radiation dosimetry of 11C-WAY100,635 in humans. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] Sati Mazumdar,et al. Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression , 2004, Neuropsychopharmacology.
[27] P A Sargent,et al. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635 , 2004, Molecular Psychiatry.
[28] Peter Herscovitch,et al. Reduced Serotonin Type 1A Receptor Binding in Panic Disorder , 2004, The Journal of Neuroscience.
[29] Philippe Courtet,et al. Serotonin transporter gene may be involved in short-term risk of subsequent suicide attempts , 2003, Biological Psychiatry.
[30] Gustavo Turecki,et al. Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide , 2003, The Journal of Neuroscience.
[31] C. Stockmeier. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. , 2003, Journal of psychiatric research.
[32] D. Ciraulo. Neuropsychopharmacology: The Fifth Generation of Progress , 2003 .
[33] Victoria Arango,et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635 , 2002, Brain Research.
[34] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[35] P. Cowen,et al. State and trait abnormalities in serotonin function in major depression. , 2002, The British journal of psychiatry : the journal of mental science.
[36] F. Turkheimer,et al. 5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochlori , 2002, The Journal of pharmacology and experimental therapeutics.
[37] L. Naudon,et al. A chronic treatment with fluoxetine decreases 5-HT1A receptors labeling in mice selected as a genetic model of helplessness , 2002, Brain Research.
[38] Roger N. Gunn,et al. A Database of [11C]WAY-100635 Binding to 5-HT1A Receptors in Normal Male Volunteers: Normative Data and Relationship to Methodological, Demographic, Physiological, and Behavioral Variables , 2002, NeuroImage.
[39] Daniel J Buysse,et al. Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: II. comparison during remission , 2002, Biological Psychiatry.
[40] M Slifstein,et al. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. , 2001, Nuclear medicine and biology.
[41] Stephen M. Smith,et al. A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..
[42] Shitij Kapur,et al. Serotonin 5-HT1A Receptor Binding Potential Declines with Age as Measured by [11C]WAY-100635 and PET , 2001, Neuropsychopharmacology.
[43] Chester A. Mathis,et al. Gender-specific aging effects on the serotonin 1A receptor , 2001, Brain Research.
[44] 陳進明,et al. Serotonin , 2001 .
[45] M Slifstein,et al. Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[46] M Slifstein,et al. Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions. , 2000, Nuclear medicine and biology.
[47] P A Sargent,et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.
[48] D. Kupfer,et al. Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.
[49] R. Bornstein,et al. Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task. , 1999, Neuropsychology.
[50] J. Flory,et al. Recovery from Major Depression Is Not Associated with Normalization of Serotonergic Function , 1998, Biological Psychiatry.
[51] G Brix,et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[52] Allan L. Reiss,et al. Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome , 1997, Psychiatry Research: Neuroimaging.
[53] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[54] Daniel J Buysse,et al. Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: I. Comparison during acute depressive states , 1995, Biological Psychiatry.
[55] P B Hoffer,et al. Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] W. Bank. The Human Brain. Surface, Three-Dimensional Sectional Anatomy and MRI , 1993 .
[57] G. Burrows. Long-term treatments of recurrent depressive disorders. , 1992 .
[58] D. Kupfer,et al. EEG sleep profiles and recurrent depression , 1991, Biological Psychiatry.
[59] E. Cabanis,et al. The Human Brain: Surface, Three-Dimensional Sectional Anatomy and Mri , 1991 .
[60] J. Talairach,et al. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .
[61] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[62] J. Fleiss,et al. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.
[63] D Lester,et al. The measurement of pessimism: the hopelessness scale. , 1974, Journal of consulting and clinical psychology.
[64] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[65] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[66] R Todd Ogden,et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. , 2006, The American journal of psychiatry.
[67] David Goldman,et al. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. , 2006, The American journal of psychiatry.
[68] B. Lebowitz,et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.
[69] Dennis S. Charney,et al. Neuropsychopharmacology : The Fifth Generation of Progress , 2002 .
[70] J. Ashburner,et al. Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.
[71] T Sandor,et al. An interactive procedure for extracting features of the brain from magnetic resonance images: The lobes , 1997, Human brain mapping.
[72] D. Newport,et al. A Single Scatter Simulation Technique for Scatter Correction in 3D PET , 1996 .
[73] M. Thase. Long-term treatments of recurrent depressive disorders. , 1992, The Journal of clinical psychiatry.
[74] Andrew P. Smith,et al. State and trait , 1992 .